CS Diagnostics Corp.
CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The compa… Read more
CS Diagnostics Corp. (CSDX) - Total Liabilities
Latest total liabilities as of September 2025: $1.61K USD
Based on the latest financial reports, CS Diagnostics Corp. (CSDX) has total liabilities worth $1.61K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CS Diagnostics Corp. - Total Liabilities Trend (None–None)
This chart illustrates how CS Diagnostics Corp.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CS Diagnostics Corp. Competitors by Total Liabilities
The table below lists competitors of CS Diagnostics Corp. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hankukpackage Co. Ltd
KQ:037230
|
Korea | ₩104.75 Billion |
|
Future Enterprises Limited
NSE:FELDVR
|
India | ₹61.23 Billion |
|
Thunder Mountain Gold Inc
OTCQB:THMG
|
USA | $1.40 Million |
|
Tower Resources Ltd
PINK:TWRFF
|
USA | $226.45K |
|
Table Trac Inc
OTCQX:TBTC
|
USA | $1.39 Million |
|
Ostim Endustriyel Yatirimlar ve Isletme AS
IS:OSTIM
|
Turkey | TL399.06 Million |
|
PPX Mining Corp
PINK:SNNGF
|
USA | $53.27 Million |
|
Tong-Hwa Synthetic Fiber Co Ltd
TW:1418
|
Taiwan | NT$4.10 Billion |
Liability Composition Analysis (None–None)
This chart breaks down CS Diagnostics Corp.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 19.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.00 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.00 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CS Diagnostics Corp.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CS Diagnostics Corp. (None–None)
The table below shows the annual total liabilities of CS Diagnostics Corp. from None to None.
| Year | Total Liabilities | Change |
|---|---|---|
| No yearly data available. | ||